1 / 37

http://. Dr. Yoseph Glovinsky. www. Xala.com. www.xala.com.il. כנסו! כדאי!. Welcome to Xala.com Israel. Who we are Assess your knowledge About our product Information for advanced users Frequently asked questions Write to us. Who we are. Glovinsky playing Konstas (2)

Download Presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. http:// Dr. Yoseph Glovinsky

  2. www

  3. Xala.com

  4. www.xala.com.il כנסו! כדאי!

  5. Welcome to Xala.com Israel • Who we are • Assess your knowledge • About our product • Information for advanced users • Frequently asked questions • Write to us

  6. Who we are • Glovinsky playing Konstas (2) • Also Feldman (1) Diestelhorst (1) and Glovinsky (?).

  7. Welcome to Xala.com Israel • Who we are • Assess your knowledge • About our product • Information for advanced users • Frequently asked questions • Write to us

  8. Assess your knowledge:Mono quizCombo quiz 1Combo quiz 2Paper Quiz

  9. Mono quiz:Which is more effective? • Xalatan intracameral • Xalatan topical • Xalatan subtenon’s • Xalatan retrobulbar

  10. Combo-quiz 1:Which has been shown to be more effective? • Xalacom at 8 AM • Xalacom at 8 AM & 8 PM • Xalacom at 8 PM • Xalacom at 12 PM

  11. Combo-quiz 2:What is “Predicom”? • Prednison-ofloxacin combination • Prediction of Xalacom efficacy • Prednison-neomycin combination • Prediction of Xalacom safety

  12. Paper Quiz:What is the second most important part of a scientific paper dealing with medication efficacy? • Title • Introduction • Patients and methods • Discussion

  13. Welcome to Xala.com Israel • Who we are • Assess your knowledge • About our product • Information for advanced users • Frequently asked questions • Write to us

  14. About our product: • Fixed combination of Xalatan & Timolol • To be used in glaucoma patients inadequately controlled with beta-blockers alone • Once daily evening dosage recommended • Twice daily dosage not recommended • Once daily morning or noon dosage - possible

  15. Welcome to Xala.com Israel • Who we are • Assess your knowledge • About our product • Information for advanced users • Frequently asked questions • Write to us

  16. Xalatan/timolol vs. Timolol

  17. Xalatan/timolol vs. Timololin timolol responders

  18. Xalatan/timolol vs. Timololin timolol responders 30 29 28 27 26 No Rx 25 timolol Timolol+Xalatan

  19. Xalacom vs. Xalatan

  20. Patient selection by Konstas: • Responders to individual components • POAG rather than OHT • High baseline IOP

  21. Xalacom vs. Xalatan & Timolol

  22. Xalacom vs. Xalatan & Timolol

  23. Xalacom vs. Xalatan & Timolol

  24. Xalacom vs. Xalatan & Timolol

  25. Xalatan

  26. Timolol

  27. Xalacom vs. Cosopt Eye-pain: 12% Cosopt, 4% xalacom.

  28. Xalacom vs. Cosopt

  29. Welcome to Xala.com Israel • Who we are • Assess your knowledge • About our product • Information for advanced users • Frequently asked questions • Write to us

  30. Frequently asked questions: • Q: How to implement the information for advanced users?

  31. Frequently asked questions: • Q: How to implement the information for advanced users. • A: New POAG patient with IOP 25, establish target IOP (say 16-18). Begin with timolol or xalatan. If you have reached target IOP – stay there. If IOP on one medication is higher than 22 - switch to the other medication. If 22 or lower - switch to Xalacom

  32. Frequently asked questions: • Q: What is Predicom?

  33. Predicom, 250 centers, N=770, France • Predicom, Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure • Patient with OHT or OAG with an IOP ³ 21 mmHg • Patient on beta-blockers monotherapy and requiring a change of medication due to insufficient response to treatment • age, sex, ethnic origin, patient's medical history, family history of OAG or OHT, concomitant systemic treatment with beta-blockers, etiology, IOP at baseline, corneal thickness, compliance, and adverse events

  34. Frequently asked questions: • ש: ד"ר נכבד, אני בת 28 בחודש 9. מעוניינת מאד להניק את בני שייוולד. עקב גלאוקומה אני זקוקה לטיפול בטיפות. מהי הצעתך? בתודה, גלית.

  35. For nursing mothers • Consider xalatan ! • After topical administartion: • Peak in plasma 5 minutes • Half life in plasma17 minutes! • Recommendation: In the evening extract milk and keep for next feeding, then apply Xalatan Two hours later - extract and discard all milk. Feed your baby with the extracted milk. Thereafter - continue breast feeding until next evening!

  36. Welcome to Xala.com Israel • Who we are • Assess your knowledge • About our product • Information for advanced users • Frequently asked questions • Write to us

  37. Write to us • ד"ר נכבד. המון המון תודה על העצה. זה פשוט גדול. את החלב שאני לא משתמשת להנקה (כי יש בו קסלטן) אני מוסיפה לשמפו החפיפה של שחר. תשמע השערות שיש לו – חבל על הזמן... גלית.

More Related